Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies-Reference-Cited by-同舟云学术

Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies

Published:2005-05 Issue:5 Volume:52 Page:810-822
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Paller Amy S.,Lebwohl Mark,Fleischer Alan B.,Antaya Richard,Langley Richard G.,Kirsner Robert S.,Blum Robin R.,Rico M. Joyce,Jaracz Eileen,Crowe Andrew,Linowski Gregory J.

Publisher

Elsevier BV

Subject

Dermatology

Reference17 articles.

1. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children;Boguniewicz;J Allergy Clin Immunol,1998

2. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients;Paller;J Am Acad Dermatol,2001

3. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis;Reitamo;J Allergy Clin Immunol,2002

4. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children;Kang;J Am Acad Dermatol,2001

5. A short-term trial of tacrolimus ointment for atopic dermatitis;Ruzicka;N Engl J Med,1997

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Atopic Dermatitis in Children;Cureus;2024-09-14

2. Topical anti-inflammatory treatments for eczema: network meta-analysis;Cochrane Database of Systematic Reviews;2024-08-06

3. Topical Tacrolimus and Pimecrolimus in Dermatology: An Overview;Clinical Dermatology Review;2024-07

4. Advancing Treatment in Atopic Dermatitis: A Comprehensive Review of Clinical Efficacy, Safety, and Comparative Insights Into Corticosteroids, Calcineurin Inhibitors, and Phosphodiesterase-4 Inhibitors as Topical Therapies;Cureus;2024-03-02

5. Topical Prescription Management;Advances in Experimental Medicine and Biology;2024